Common hair loss medications with men’s erection and sexual confusion

A 28-year-old man revealed a painful nine-month struggle with a popular hair loss drug struggle, describing how he stopped taking it once his life was turned upside down.

In a man on Chirag, he said on the podcast “Ethical Medicine” that he lived a wonderful life to deal with hair loss before starting to pop up finasteride in June 2023.

He has known friends who have had no problems for many years, and he does show that most internet studies have shown that posttinibline syndrome (PFS) (someone experiences serious side effects after stopping Finastalide, “not real.”

He obtained the medication through him, claiming the telemedicine company “emitted like candy – without any process.” The position contacted him for comment.

“I don’t know what I’m doing,” Chirag said.

He started taking one medication every day, and then he started experiencing side effects—mostly sexual—so he decided to stop taking the medication and felt normal again after a few weeks.

He did more research, and at this point he made a “huge mistake” because he was just an overdose thing.

“I feel like if there was more education about it, I could have saved it from this syndrome,” he said.

After the patching dose, he noticed that he was no longer establishing in the morning, so he stopped using it again in January 2024.

Three months later, he experienced “significant, burning pain” in the pelvic area – a symptom that lasted intermittently for several months before it could go away.

Suddenly, he had a “crazy high sexual desire” so he thought the drug only took six months to completely break out of his system.

Then, on July 9, “something just closed,” he said. “I was actually powerless for three weeks.”

Then, it did get worse.

“A month later, I started to have crazy insomnia – I didn’t sleep for 10 days in a row,” he said. “That’s hell. I’m an S-T-shaped.”

He also experienced severe weight and muscle loss, “genital changes”, and pelvic pain recovered with revenge, preventing him from “sitting right”.

He saw a urologist who seemed to ignore PFS but prescribed him cialis and told him to see a pelvic floor specialist.

He changed his diet and started physical therapy, which seemed to help with sexual dysfunction and muscle loss – and then he “crashed” again.

“I feel like I’ve completely degenerated,” he said. “My bones squeak like crazy – it’s scary…I can’t fall asleep anymore…I have these rashes on my skin now…the sexual function has subsided.”

“Every month, I feel like there are new side effects,” he added. “It really completely changed my life.”

Podcast host Mark Millich, interviewed by Chirag, who made headlines last month by telling the Wall Street Journal.

Some side effects include anxiety, dizziness and speech. His sexual desire also plummeted, his genitals shrank and changed shape.

“This drug has been on the market for thirty years and people have been dealing with this time and doing nothing,” Milich said on the podcast. “There is no more excuses for the healthcare system. It’s disgusting.”

Last week, the U.S. Food and Drug Administration issued a warning about a local finasteride product issued by telemedicine companies and quoted several reports of adverse events such as erectile dysfunction, anxiety, suicidal thoughts, brain fog, depression, depression, fatigue, insomnia, reduced libido and testicular pain.

The warning specifically targets the spray formula of finasteride, and the active ingredients are also found in the oral drug proecia.

The FDA said these partial versions have not yet been officially approved and have not submitted comprehensive security data to them.

Telemedicine companies have also come under fire for allegedly failing to adequately screen customers’ drugs.

WSJ and none of the 17 male telemedicine clients who reported serious side effects believed they were properly aware of the risks.

A HIMS spokesperson told the media that its clients “experienced a comprehensive intake reviewed by a licensed provider that qualifies patients for clinical determination of medications” and that the company communicated “all basic details and safety information.”

As for Chirag? “I just want my life back,” he said.